Biblio

Found 7 results
Filters: Keyword is Registries  [Clear All Filters]
2015
Andersson NW, Gustafsson LN, Okkels N, Taha F, Cole SW, Munk-Jørgensen P, Goodwin RD.  2015.  Depression and the risk of autoimmune disease: a nationally representative, prospective longitudinal study.. Psychol Med. 45(16):3559-69.
2014
Owen JE, Bantum EO'Carroll, Criswell K, Bazzo J, Gorlick A, Stanton AL.  2014.  Representativeness of two sampling procedures for an internet intervention targeting cancer-related distress: a comparison of convenience and registry samples.. J Behav Med. 37(4):630-41.
2013
Sørensen GVrelits, Ganz PA, Cole SW, Pedersen LA, Sørensen HToft, Cronin-Fenton DP, Garne JPeter, Christiansen PM, Lash TL, Ahern TP.  2013.  Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.. J Clin Oncol. 31(18):2265-72.
2011
Ganz PA, Habel LA, Weltzien EK, Caan BJ, Cole SW.  2011.  Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.. Breast Cancer Res Treat. 129(2):549-56.
2010
Sanders SL, Bantum EO, Owen JE, Thornton AA, Stanton AL.  2010.  Supportive care needs in patients with lung cancer.. Psychooncology. 19(5):480-9.
2008
Beran TM, Stanton AL, Kwan L, Seldon J, Bower JE, Vodermaier A, Ganz PA.  2008.  The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Ann Behav Med. 36(2):107-16.
2007
O'Connor M-F, Irwin MR, Seldon J, Kwan L, Ganz PA.  2007.  Pro-inflammatory cytokines and depression in a familial cancer registry.. Psychooncology. 16(5):499-501.